06 Nov 2026, 06:42 IST
IPCA Laboratories Limited
HDFC Securities · BUY · target INR2,240
The report says IPCA's EBITDA grew 21% YoY with margin expansion to 23%, retaining FY27 guidance, and raises TP to INR2,240 maintaining BUY.
From HSIE Results Daily 06 Nov 26 HSIE, written by HDFC Securities. Orivam summarised it; the view is HDFC Securities's, not Orivam's.
Open the original PDF →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.